[1]
C. A. Morton, “BF-200 ALA for the Photodynamic Treatment of Non-Aggressive Basal Cell Carcinoma: Results of a Phase III Comparator Trial”, J of Skin, vol. 1, no. 3.1, p. s112, Oct. 2017.